Functional roles of protein nitration in acute and chronic liver diseases

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Abdelmegeed, Mohamed A ^a   Song, Byoung Joon ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR BIOLOGY; NITRATION; NITRIC OXIDE; OXYGEN; TISSUE;

CHRONIC LIVER DISEASE; IMMUNOLOGICAL METHODS; LABOR INTENSIVENESS; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGICAL TISSUE; PROTEIN NITRATION; TRANSLATIONAL RESEARCH; TYROSINE RESIDUES;

PROTEINS;

PEPTIDE; PEROXYNITROUS ACID; PROTEIN;

ACUTE DISEASE; ANIMAL; CHEMISTRY; CHRONIC DISEASE; HUMAN; IMMUNOASSAY; LIVER DISEASE; METABOLISM; MITOCHONDRION; PATHOLOGY; PROTEOMICS;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; HUMANS; IMMUNOASSAY; LIVER DISEASES; MITOCHONDRIA; PEPTIDES; PEROXYNITROUS ACID; PROTEINS; PROTEOMICS;

EID: 84901379933     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/149627     Document Type: Review

References (218)

1. Nathan C., Nitric oxide as a secretory product of mammalian cells. The FASEB Journal 1992 6 12 3051 3064 2-s2.0-0026629902
2. Bredt D. S., Hwang P. M., Snyder S. H., Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990 347 6295 768 770 2-s2.0-0025011298 10.1038/347768a0 (Pubitemid 20370722)
3. Bredt D. S., Snyder S. H., Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proceedings of the National Academy of Sciences of the United States of America 1989 86 22 9030 9033 2-s2.0-0024378999 10.1073/pnas.86.22.9030 (Pubitemid 20010361)
4. Pacher P., Beckman J. S., Liaudet L., Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 2007 87 1 315 424 2-s2.0-33846863589 10.1152/physrev.00029.2006 (Pubitemid 46217686)
5. Koeck T., Fu X., Hazen S. L., Crabb J. W., Stuehr D. J., Aulak K. S., Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. Journal of Biological Chemistry 2004 279 26 27257 27262 2-s2.0-3042646339 10.1074/jbc.M401586200 (Pubitemid 38812564)
6. Saxena I., Shekhawat G. S., Nitric oxide (NO) in alleviation of heavy metal induced phytotoxicity and its role in protein nitration. Nitric Oxide 2013 32 13 20
7. Martínez-Ruiz A., Cadenas S., Lamas S., Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Radical Biology and Medicine 2011 51 1 17 29 2-s2.0-79957933470 10.1016/j.freeradbiomed.2011.04.010
8. Song B. J., Abdelmegeed M. A., Henderson L. E., Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease. Oxidative Medicine and Cellular Longevity 2013 2013 14 781050 10.1155/2013/781050
9. Calcerrada P., Peluffo G., Radi R., Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications. Current Pharmaceutical Design 2011 17 35 3905 3932 2-s2.0-83455170695
10. Radi R., Beckman J. S., Bush K. M., Freeman B. A., Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. Journal of Biological Chemistry 1991 266 7 4244 4250 2-s2.0-0025730414 (Pubitemid 21909347)
11. Lancaster J. R. Jr., Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chemical Research in Toxicology 2006 19 9 1160 1174 2-s2.0-33749005136 10.1021/tx060061w (Pubitemid 44454032)
12. Caro A. A., Cederbaum A. I., Oxidative stress, toxicology, and pharmacology of CYP2E1. Annual Review of Pharmacology and Toxicology 2004 44 27 42 2-s2.0-1342323673 10.1146/annurev.pharmtox.44.101802.121704 (Pubitemid 38263832)
13. Purohit V., Gao B., Song B.-J., Molecular mechanisms of alcoholic fatty liver. Alcoholism: Clinical and Experimental Research 2009 33 2 191 205 2-s2.0-58849156556 10.1111/j.1530-0277.2008.00827.x
14. Cohen J. I., Chen X., Nagy L. E., Redox signaling and the innate immune system in alcoholic liver disease. Antioxidants and Redox Signaling 2011 15 2 523 534 2-s2.0-79959497081 10.1089/ars.2010.3746
15. McKim S. E., Gäbele E., Isayama F., Lambert J. C., Tucker L. M., Wheeler M. D., Connor H. D., Mason R. P., Doll M. A., Hein D. W., Arteel G. E., Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 2003 125 6 1834 1844 2-s2.0-10744232492 10.1053/j.gastro.2003.08.030 (Pubitemid 37500447)
16. Venkatraman A., Shiva S., Wigley A., Ulasova E., Chhieng D., Bailey S. M., Darley-Usmar V. M., The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice. Hepatology 2004 40 3 565 573 2-s2.0-4544327270 10.1002/hep.20326 (Pubitemid 39265577)
17. Purohit V., Rapaka R., Kwon O. S., Song B. J., Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma. Life Sciences 2013 92 1 3 9 10.1016/j.lfs.2012.10.009
18. Bansal S., Liu C.-P., Sepuri N. B. V., Anandatheerthavarada H. K., Selvaraj V., Hoek J., Milne G. L., Guengerich F. P., Avadhani N. G., Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. Journal of Biological Chemistry 2010 285 32 24609 24619 2-s2.0-77955294012 10.1074/jbc.M110.121822
19. Leclercq I. A., Farrell G. C., Field J., Bell D. R., Gonzalez F. J., Robertson G. R., CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. Journal of Clinical Investigation 2000 105 8 1067 1075 2-s2.0-0034092716 (Pubitemid 30217691)
20. Nuriel T., Hansler A., Gross S. S., Protein nitrotryptophan: formation, significance and identification. Journal of Proteomics 2011 74 11 2300 2312 2-s2.0-80054855465 10.1016/j.jprot.2011.05.032
21. Kansanen E., Jyrkkänen H.-K., Levonen A.-L., Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids. Free Radical Biology and Medicine 2012 52 6 973 982 2-s2.0-84857233782 10.1016/j. freeradbiomed.2011.11.038
22. Patel A., Liebner F., Netscher T., Mereiter K., Rosenau T., Vitamin E chemistry. Nitration of non- α -tocopherols: products and mechanistic considerations. Journal of Organic Chemistry 2007 72 17 6504 6512 2-s2.0-34547943504 10.1021/jo0706832 (Pubitemid 47267574)
23. Nakamura M., Nagayoshi R., Ijiri K., Nakashima-Matsushita N., Takeuchi T., Matsuyama T., Nitration and chlorination of folic acid by peroxynitrite and hypochlorous acid, and the selective binding of 10-nitro-folate to folate receptor β Biochemical and Biophysical Research Communications 2002 297 5 1238 1244 2-s2.0-0036399610 10.1016/S0006-291X(02)02359-8 (Pubitemid 35216380)
24. Berlett B. S., Levine R. L., Stadtman E. R., Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation. Proceedings of the National Academy of Sciences of the United States of America 1998 95 6 2784 2789 2-s2.0-0032539899 10.1073/pnas.95.6.2784 (Pubitemid 28135806)
25. Knapp L. T., Kanterewicz B. I., Hayes E. L., Klann E., Peroxynitrite-induced tyrosine nitration and inhibition of protein kinase C. Biochemical and Biophysical Research Communications 2001 286 4 764 770 2-s2.0-0034816642 10.1006/bbrc.2001.5448 (Pubitemid 32912953)
26. Ischiropoulos H., Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Archives of Biochemistry and Biophysics 1998 356 1 1 11 2-s2.0-0032147208 10.1006/abbi.1998.0755 (Pubitemid 28364347)
27. Souza J. M., Daikhin E., Yudkoff M., Raman C. S., Ischiropoulos H., Factors determining the selectivity of protein tyrosine nitration. Archives of Biochemistry and Biophysics 1999 371 2 169 178 2-s2.0-0033571792 10.1006/abbi.1999.1480
28. Kyte J., Doolittle R. F., A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 1982 157 1 105 132 2-s2.0-0020475449
29. Bregere C., Rebrin I., Sohal R. S., Detection and characterization of in vivo nitration and oxidation of tryptophan residues in proteins. Methods in Enzymology 2008 441 339 349 2-s2.0-52049093858 10.1016/S0076-6879(08)01219-6
30. Yamakura F., Kawasaki H., Post-translational modifications of superoxide dismutase. Biochimica et Biophysica Acta 2010 1804 2 318 325 2-s2.0-74449090930 10.1016/j.bbapap.2009.10.010
31. Deeb R. S., Nuriel T., Cheung C., Summers B., Lamon B. D., Gross S. S., Hajjar D. P., Characterization of a cellular denitrase activity that reverses nitration of cyclooxygenase. The American Journal of Physiology-Heart and Circulatory Physiology 2013 305 5 H687 H698 10.1152/ajpheart.00876.2012
32. Greenacre S., Ischiropoulos H., Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radical Research 2001 34 6 541 581 2-s2.0-0034925593 (Pubitemid 32694646)
33. Takakusa H., Mohar I., Kavanagh T. J., Kelly E. J., Kaspera R., Nelson S. D., Protein tyrosine nitration of mitochondrial carbamoyl phosphate synthetase 1 and its functional consequences. Biochemical and Biophysical Research Communications 2012 420 1 54 60 2-s2.0-84859109176 10.1016/j.bbrc.2012.02.114
34. Görg B., Wettstein M., Metzger S., Schliess F., Häussinger D., Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology 2005 41 5 1065 1073 2-s2.0-17844375087 10.1002/hep.20662 (Pubitemid 40593914)
35. Abdelmegeed M. A., Jang S., Banerjee A., Hardwick J. P., Song B. J., Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radical Biology and Medicine 2013 60 211 222 10.1016/j.freeradbiomed.2013.02.018
36. Larosche I., Lettéron P., Berson A., Fromenty B., Huang T.-T., Moreau R., Pessayre D., Mansouri A., Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase. Journal of Pharmacology and Experimental Therapeutics 2010 332 3 886 897 2-s2.0-77249134288 10.1124/jpet.109.160879
37. Moon K.-H., Hood B. L., Kim B.-J., Hardwick J. P., Conrads T. P., Veenstra T. D., Song B. J., Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 2006 44 5 1218 1230 2-s2.0-33751003258 10.1002/hep.21372 (Pubitemid 44748372)
38. Moon K.-H., Upreti V. V., Yu L.-R., Lee I. J., Ye X., Eddington N. D., Veenstra T. D., Song B.-J., Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 2008 8 18 3906 3918 2-s2.0-53549125568 10.1002/pmic.200800215
39. Lin H.-L., Myshkin E., Waskell L., Hollenberg P. F., Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation. Chemical Research in Toxicology 2007 20 11 1612 1622 2-s2.0-37249051057 10.1021/tx700220e (Pubitemid 350275606)
40. Abdelmegeed M. A., Moon K.-H., Chen C., Gonzalez F. J., Song B.-J., Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochemical Pharmacology 2010 79 1 57 66 2-s2.0-70350202531 10.1016/j.bcp.2009.07.016
41. Ji Y., Neverova I., van Eyk J. E., Bennett B. M., Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione S-transferase by peroxynitrite. Journal of Biological Chemistry 2006 281 4 1986 1991 2-s2.0-33644850478 10.1074/jbc.M509480200 (Pubitemid 43845785)
42. Savvides S. N., Scheiwein M., Böhme C. C., Arteel G. E., Andrew Karplus P., Becker K., Heiner Schirmer R., Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite. Journal of Biological Chemistry 2002 277 4 2779 2784 2-s2.0-0037169547 10.1074/jbc.M108190200 (Pubitemid 34953308)
43. Francescutti D., Baldwin J., Lee L., Mutus B., Peroxynitrite modification of glutathione reductase: modeling studies and kinetic evidence suggest the modification of tyrosines at the glutathione disulfide binding site. Protein Engineering 1996 9 2 189 194 2-s2.0-0029933254 (Pubitemid 26119300)
44. Fujimoto M., Shimizu N., Kunii K., Martyn J. A. J., Ueki K., Kaneki M., A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 2005 54 5 1340 1348 2-s2.0-17844367159 10.2337/diabetes.54.5.1340 (Pubitemid 40586662)
45. Reinehr R., Görg B., Höngen A., Häussinger D., CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes. Journal of Biological Chemistry 2004 279 11 10364 10373 2-s2.0-1642409200 10.1074/jbc.M311997200 (Pubitemid 38372644)
46. Elfering S. L., Haynes V. L., Traaseth N. J., Ettl A., Giulivi C., Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. The American Journal of Physiology-Heart and Circulatory Physiology 2004 286 1 H22 H29 2-s2.0-0347117585 (Pubitemid 38049458)
47. Jian-Hong Zhu J.-H. Z., Zhang X., Roneker C. A., McClung J. P., Zhang S., Thannhauser T. W., Ripoll D. R., Sun Q., Lei X. G., Role of copper,zinc-superoxide dismutase in catalyzing nitrotyrosine formation in murine liver. Free Radical Biology and Medicine 2008 45 5 611 618 2-s2.0-48449095019 10.1016/j.freeradbiomed.2008.05.018
48. Franco M. C., Ye Y., Refakis C. A., Nitration of Hsp90 induces cell death. Proceedings of the National Academy of Sciences of the United States of America 2013 110 12 E1102 E1111 10.1073/pnas.1215177110
49. Wu F., Wilson J. X., Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction. Cardiovascular Research 2009 81 1 38 45 2-s2.0-57749176350 10.1093/cvr/cvn246
50. Souza J. M., Peluffo G., Radi R., Protein tyrosine nitration-functional alteration or just a biomarker? Free Radical Biology and Medicine 2008 45 4 357 366 2-s2.0-46649090918 10.1016/j.freeradbiomed.2008.04.010
51. Abello N., Kerstjens H. A. M., Postma D. S., Bischoff R., Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. Journal of Proteome Research 2009 8 7 3222 3238 2-s2.0-67650354415 10.1021/pr900039c
52. Grune T., Blasig I. E., Sitte N., Roloff B., Haseloff R., Davies K. J. A., Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. Journal of Biological Chemistry 1998 273 18 10857 10862 2-s2.0-0032080117 10.1074/jbc.273.18.10857 (Pubitemid 28204920)
53. Souza J. M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., Obin M., Ara J., Horwitz J., Ischiropoulos H., Proteolytic degradation of tyrosine nitrated proteins. Archives of Biochemistry and Biophysics 2000 380 2 360 366 2-s2.0-0034663360 10.1006/abbi.2000.1940 (Pubitemid 30659107)
54. Schildknecht S., Gerding H. R., Karreman C., Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Journal of Neurochemistry 2013 125 4 491 511 10.1111/jnc.12226
55. Chavarria C., Souza J. M., Oxidation and nitration of alpha-synuclein and their implications in neurodegenerative diseases. Archives of Biochemistry and Biophysics 2013 533 1-2 25 32 10.1016/j.abb.2013.02.009
56. Ciechanover A., The ubiquitin-proteasome proteolytic pathway. Cell 1994 79 1 13 21 2-s2.0-0028018268 10.1016/0092-8674(94)90396-4 (Pubitemid 24309509)
57. Ciechanover A., Schwartz A. L., The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death. Proceedings of the National Academy of Sciences of the United States of America 1998 95 6 2727 2730 2-s2.0-0032539909 10.1073/pnas.95.6.2727 (Pubitemid 28135795)
58. Brandon-Warner E., Schrum L. W., Schmidt C. M., McKillop I. H., Rodent models of alcoholic liver disease: of mice and men. Alcohol 2012 46 8 715 725 10.1016/j.alcohol.2012.08.004
59. Bertola A., Mathews S., Ki S. H., Wang H., Gao B., Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nature Protocols 2013 8 3 627 637 10.1038/nprot.2013.032
60. Wang J.-F., Greenberg S. S., Spitzer J. J., Chronic alcohol administration stimulates nitric oxide formation in the rat liver with or without pretreatment by lipopolysaccharide. Alcoholism: Clinical and Experimental Research 1995 19 2 387 393 2-s2.0-0028930465
61. Kessova I. G., Ho Y.-S., Thung S., Cederbaum A. I., Alcohol-induced liver injury in mice lacking Cu, Zn-superoxide dismutase. Hepatology 2003 38 5 1136 1145 2-s2.0-0142182787 10.1053/jhep.2003.50450 (Pubitemid 37314822)
62. Kim B.-J., Hood B. L., Aragon R. A., Hardwick J. P., Conrads T. P., Veenstra T. D., Song B. J., Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells. Proteomics 2006 6 4 1250 1260 2-s2.0-33644500142 10.1002/pmic.200500447
63. Feldstein A. E., Novel insights into the pathophysiology of nonalcoholic fatty liver disease. Seminars in Liver Disease 2010 30 4 391 401 2-s2.0-77958183243 10.1055/s-0030-1267539
64. Feldstein A. E., Bailey S. M., Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease. Antioxidants and Redox Signaling 2011 15 2 421 424 2-s2.0-79959501180 10.1089/ars.2011.3897
65. French S. W., Benson N. C., Sun P. S., Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology 1984 4 5 912 917 2-s2.0-0021170722 (Pubitemid 14007665)
66. Tsukamoto H., Xi X. P., Incomplete compensation of enhanced hepatic oxygen consumption in rats with alcoholic centrilobular liver necrosis. Hepatology 1989 9 2 302 306 2-s2.0-0024593463 (Pubitemid 19063318)
67. Song B.-J., Moon K.-H., Olsson N. U., Salem N. Jr., Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. Journal of Hepatology 2008 49 2 262 273 2-s2.0-46149111662 10.1016/j.jhep.2008.04.023
68. Suzuki T., Murakami T., Iino R., Suzuki J., Ono S., Shirakihara Y., Yoshida M., F0F1-ATPase/synthase is geared to the synthesis mode by conformational rearrangement of ε subunit in response to proton motive force and ADP/ATP balance. Journal of Biological Chemistry 2003 278 47 46840 46846 2-s2.0-0345306622 10.1074/jbc.M307165200 (Pubitemid 37452264)
69. Radi R., Cassina A., Hodara R., Nitric oxide and peroxynitrite interactions with mitochondria. Biological Chemistry 2002 383 3-4 401 409 2-s2.0-0036244508 10.1515/BC.2002.044 (Pubitemid 34506280)
70. Venkatraman A., Landar A., Davis A. J., Chamlee L., Sanderson T., Kim H., Page G., Pompilius M., Ballinger S., Darley-Usmar V., Bailey S. M., Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. Journal of Biological Chemistry 2004 279 21 22092 22101 2-s2.0-2542475915 10.1074/jbc.M402245200 (Pubitemid 38679401)
71. Mansouri A., Tarhuni A., Larosche I., Reyl-Desmars F., Demeilliers C., Degoul F., Nahon P., Sutton A., Moreau R., Fromenty B., Pessayre D., MnSOD overexpression prevents liver mitochondrial DNA depletion after an alcohol binge but worsens this effect after prolonged alcohol consumption in mice. Digestive Diseases 2010 28 6 756 775 2-s2.0-79955642700 10.1159/000324284
72. Zelickson B. R., Benavides G. A., Johnson M. S., Chacko B. K., Venkatraman A., Landar A., Betancourt A. M., Bailey S. M., Darley-Usmar V. M., Nitric oxide and hypoxia exacerbate alcohol-induced mitochondrial dysfunction in hepatocytes. Biochimica et Biophysica Acta 2011 1807 12 1573 1582 2-s2.0-81155148125 10.1016/j.bbabio.2011.09.011
73. Venkatraman A., Shiva S., Davis A. J., Bailey S. M., Brookes P. S., Darley-Usmar V. M., Chronic alcohol consumption increases the sensitivity of rat liver mitochondrial respiration to inhibition by nitric oxide. Hepatology 2003 38 1 141 147 2-s2.0-0038121968 10.1053/jhep.2003.50293 (Pubitemid 36775805)
74. Leung T. M., Nieto N., CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. Journal of Hepatology 2013 58 2 395 398 10.1016/j.jhep.2012.08.018
75. Albano E., Clot P., Morimoto M., Tomasi A., Ingelman-Sundberg M., French S. W., Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 1996 23 1 155 163 2-s2.0-0030045690 10.1053/jhep.1996.v23. pm0008550035 (Pubitemid 26012104)
76. Lieber C. S., Cytochrome P-4502E1: its physiological and pathological role. Physiological Reviews 1997 77 2 517 544 2-s2.0-0030935567 (Pubitemid 27184347)
77. Lu Y., Cederbaum A. I., CYP2E1 and oxidative liver injury by alcohol. Free Radical Biology and Medicine 2008 44 5 723 738 2-s2.0-39149123560 10.1016/j.freeradbiomed.2007.11.004
78. Abdelmegeed M. A., Banerjee A., Jang S., CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radical Biology and Medicine 2013 65 1238 1245 10.1016/j.freeradbiomed.2013.09.009
79. Morgan K., French S. W., Morgan T. R., Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 2002 36 1 122 134 (Pubitemid 34700769)
80. Butura A., Nilsson K., Morgan K., The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. Journal of Hepatology 2009 50 3 572 583 10.1016/j.jhep.2008.10.020
81. Lu Y., Wu D., Wang X., Ward S. C., Cederbaum A. I., Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radical Biology and Medicine 2010 49 9 1406 1416 2-s2.0-77957123293 10.1016/j.freeradbiomed.2010.07.026
82. Knockaert L., Fromenty B., Robin M.-A., Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity. FEBS Journal 2011 278 22 4252 4260 2-s2.0-80255126097 10.1111/j.1742-4658.2011.08357.x
83. Raza H., Prabu S. K., Robin M.-A., Avadhani N. G., Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin- induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 2004 53 1 185 194 2-s2.0-0347360363 10.2337/diabetes.53.1.185 (Pubitemid 38044714)
84. Neve E. P. A., Ingelman-Sundberg M., Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. Journal of Biological Chemistry 2000 275 22 17130 17135 2-s2.0-0034595984 10.1074/jbc.M000957200 (Pubitemid 30398958)
85. Robin M.-A., Sauvage I., Grandperret T., Descatoire V., Pessayre D., Fromenty B., Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. FEBS Letters 2005 579 30 6895 6902 2-s2.0-28844436028 10.1016/j.febslet.2005.11.029 (Pubitemid 41773706)
86. Clayburgh D. R., Shen L., Turner J. R., A porous defense: the leaky epithelial barrier in intestinal disease. Laboratory Investigation 2004 84 3 282 291 2-s2.0-2142813761 10.1038/labinvest.3700050 (Pubitemid 41656483)
87. Hollander D., The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scandinavian Journal of Gastroenterology 1992 27 9 721 726 2-s2.0-0026630075
88. Keshavarzian A., Holmes E. W., Patel M., Iber F., Fields J. Z., Pethkar S., Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol- induced liver damage. The American Journal of Gastroenterology 1999 94 1 200 207 2-s2.0-0032920540 10.1111/j.1572-0241.1999.00797.x (Pubitemid 29063469)
89. Keshavarzian A., Choudhary S., Holmes E. W., Yong S., Banan A., Jakate S., Fields J. Z., Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. Journal of Pharmacology and Experimental Therapeutics 2001 299 2 442 448 2-s2.0-0034757037 (Pubitemid 32979654)
90. Keshavarzian A., Fields J., Alcohol: "ice-breaker" yes, "gut barrier-breaker," maybe. The American Journal of Gastroenterology 2000 95 5 1124 1125 2-s2.0-0034104856 10.1016/S0002-9270(00)00790-5 (Pubitemid 30263501)
91. Keshavarzian A., Fields J., Alcoholic liver disease: is it an "extraintestinal" complication of alcohol-induced intestinal injury? Journal of Laboratory and Clinical Medicine 2003 142 5 285 287 2-s2.0-0344392928 10.1016/S0022-2143(03)00140-9 (Pubitemid 37487397)
92. Robinson G. M., Orrego H., Israel Y., Low-molecular-weight polyethylene glycol as a probe of gastrointestinal permeability after alcohol ingestion. Digestive Diseases and Sciences 1981 26 11 971 977 2-s2.0-0019857243 (Pubitemid 12232249)
93. Tang Y., Banan A., Forsyth C. B., Fields J. Z., Lau C. K., Zhang L. J., Keshavarzian A., Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcoholism: Clinical and Experimental Research 2008 32 2 355 364 2-s2.0-38349109046 10.1111/j.1530-0277.2007.00584.x
94. Lambert J. C., Zhou Z., Wang L., Song Z., McClain C. J., Kang Y. J., Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice. Journal of Pharmacololgy and Experimental Therapeutics 2003 305 3 880 886 10.1124/jpet.102.047852 (Pubitemid 36617964)
95. Lambert J. C., Zhou Z., Wang L., Song Z., McClain C. J., Kang Y. J., Preservation of intestinal structural integrity by zinc is independent of metallothionein in alcohol-intoxicated mice. The American Journal of Pathology 2004 164 6 1959 1966 10.1016/S0002-9440(10)63756-X (Pubitemid 38669345)
96. Bode C., Kugler V., Bode J. C., Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. Journal of Hepatology 1987 4 1 8 14 2-s2.0-0023145010 (Pubitemid 17045538)
97. Tang Y., Forsyth C. B., Farhadi A., Rangan J., Jakate S., Shaikh M., Banan A., Fields J. Z., Keshavarzian A., Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcoholism: Clinical and Experimental Research 2009 33 7 1220 1230 2-s2.0-66749123764 10.1111/j.1530-0277.2009.00946.x
98. Forsyth C. B., Voigt R. M., Shaikh M., Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2013 305 2 G185 G195 10.1152/ajpgi.00354.2012
99. Upreti V. V., Moon K.-H., Yu L.-R., Lee I. J., Eddington N. D., Ye X., Veenstra T. D., Song B.-J., Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver. Proteomics 2011 11 2 202 211 2-s2.0-78650764265 10.1002/pmic.201000203
100. Smathers R. L., Galligan J. J., Stewart B. J., Petersen D. R., Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chemico-Biological Interactions 2011 192 1-2 107 112 2-s2.0-79958058366 10.1016/j.cbi.2011.02.021
101. Starley B. Q., Calcagno C. J., Harrison S. A., Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010 51 5 1820 1832 2-s2.0-77951456114 10.1002/hep.23594
102. Wieckowska A., McCullough A. J., Feldstein A. E., Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007 46 2 582 589 2-s2.0-34548306754 10.1002/hep.21768 (Pubitemid 47344794)
103. Aubert J., Begriche K., Knockaert L., Robin M. A., Fromenty B., Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clinics and Research in Hepatology and Gastroenterology 2011 35 10 630 637 2-s2.0-80054859494 10.1016/j.clinre.2011.04. 015
104. Jou J., Choi S. S., Diehl A. M., Mechanisms of disease progression in nonalcoholic fatty liver disease. Seminars in Liver Disease 2008 28 4 370 379 2-s2.0-56649083495 10.1055/s-0028-1091981
105. Abdelmegeed M. A., Banerjee A., Yoo S. H., Jang S., Gonzalez F. J., Song B. J., Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. Journal of Hepatology 2012 57 4 860 866 10.1016/j.jhep.2012.05.019
106. Ha S.-K., Chae C., Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity. Experimental Animals 2010 59 5 595 604 2-s2.0-78149418436 10.1538/expanim.59.595
107. Chalasani N., Christopher Gorski J., Asghar M. S., Asghar A., Foresman B., Hall S. D., Crabb D. W., Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003 37 3 544 550 2-s2.0-0037369729 10.1053/jhep.2003.50095 (Pubitemid 36258775)
108. Weltman M. D., Farrell G. C., Hall P., Ingelman-Sundberg M., Liddle C., Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998 27 1 128 133 2-s2.0-0031962151 10.1002/hep.510270121 (Pubitemid 28041545)
109. Fujita K., Nozaki Y., Yoneda M., Wada K., Takahashi H., Kirikoshi H., Inamori M., Saito S., Iwasaki T., Terauchi Y., Maeyama S., Nakajima A., Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model. Alcoholism: Clinical and Experimental Research 2010 34 supplement 1 S18 S24 2-s2.0-74849101212 10.1111/j.1530-0277.2008.00756.x
110. Seth R. K., Das S., Kumar A., CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis. Toxicology and Applied Pharmacology 2014 274 1 42 54 10.1016/j.taap.2013.10.029
111. Traber P. G., Zomer E., Therapy of experimental NASH and fibrosis with galectin inhibitors. PLoS ONE 2013 8 12 e83481
112. Wang W., Zhao C., Zhou J., Zhen Z., Wang Y., Shen C., Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis. PLoS ONE 2013 8 10 e76538
113. Solís Herruzo J. A., García Ruiz I., Pérez Carreras M., Muñoz Yagüe M. T., Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction. Revista Espanola de Enfermedades Digestivas 2006 98 11 844 874 2-s2.0-34848901213 (Pubitemid 350259114)
114. Kathirvel E., Morgan K., French S. W., Morgan T. R., Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. European Journal of Gastroenterology and Hepatology 2009 21 9 973 983 10.1097/MEG.0b013e328328f461
115. Kathirvel E., Chen P., Morgan K., French S. W., Morgan T. R., Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. Journal of Gastroenterology and Hepatology 2010 25 6 1136 1143
116. Menghini R., Casagrande V., Menini S., Marino A., Marzano V., Hribal M. L., Gentileschi P., Lauro D., Schillaci O., Pugliese G., Sbraccia P., Urbani A., Lauro R., Federici M., TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. Diabetes 2012 61 2 454 462 2-s2.0-84856551460 10.2337/db11-0613
117. Chatterjee S., Ganini D., Tokar E. J., Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis. Journal of Hepatology 2013 58 4 778 784 10.1016/j.jhep.2012.11.035
118. Li X., Li H., Lu N., Feng Y., Huang Y., Gao Z., Iron increases liver injury through oxidative/nitrative stress in diabetic rats: involvement of nitrotyrosination of glucokinase. Biochimie 2012 94 12 2620 7262 10.1016/j.biochi.2012.07.019
119. Solís-Muñoz P., Solís-Herruzo J. A., Fernández-Moreira D., Gõmez-Izquierdo E., García-Consuegra I., Muñoz-Yagüe T., García Ruiz I., Melatonin improves mitochondrial respiratory chain activity and liver morphology in ob/ob mice. Journal of Pineal Research 2011 51 1 113 123 2-s2.0-79960355602 10.1111/j.1600-079X.2011.00868.x
120. Charbonneau A., Marette A., Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes 2010 59 4 861 871 2-s2.0-77951178397 10.2337/db09-1238
121. Miyagi M., Sakaguchi H., Darrow R. M., Yan L., West K. A., Aulak K. S., Stuehr D. J., Hollyfield J. G., Organisciak D. T., Crabb J. W., Evidence that light modulates protein nitration in rat retina. Molecular & Cellular Proteomics 2002 1 4 293 303 2-s2.0-0036549782
122. 2/nitrite-induced post-translational modifications of human hemoglobin determined by mass spectrometry: redox regulation of tyrosine nitration and 3-nitrotyrosine reduction by antioxidants. ChemBioChem 2008 9 2 312 323 2-s2.0-38849105589 10.1002/cbic.200700541 (Pubitemid 351196800)
123. Chen H.-J. C., Chang C.-M., Chen Y.-M., Hemoprotein-mediated reduction of nitrated DNA bases in the presence of reducing agents. Free Radical Biology and Medicine 2003 34 2 254 268 2-s2.0-0037438968 10.1016/S0891-5849(02)01246-7 (Pubitemid 36084328)
124. Kamisaki Y., Wada K., Bian K., Balabanli B., Davis K., Martin E., Behbod F., Lee Y.-C., Murad F., An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proceedings of the National Academy of Sciences of the United States of America 1998 95 20 11584 11589 2-s2.0-0032578514 10.1073/pnas.95.20.11584 (Pubitemid 28460458)
125. Irie Y., Saeki M., Kamisaki Y., Martin E., Murad F., Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 5634 5639 2-s2.0-0037948843 10.1073/pnas. 1131756100 (Pubitemid 36576860)
126. Kuo W.-N., Kanadia R. N., Shanbhag V. P., Toro R., Denitration of peroxynitrite-treated proteins by "protein nitratases" from rat brain and heart. Molecular and Cellular Biochemistry 1999 201 1-2 11 16 2-s2.0-0033385194 (Pubitemid 30019359)
127. Görg B., Qvartskhava N., Voss P., Grune T., Häussinger D., Schliess F., Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration. FEBS Letters 2007 581 1 84 90 2-s2.0-33845653680 10.1016/j.febslet.2006.11.081 (Pubitemid 44960284)
128. Smallwood H. S., Lourette N. M., Boschek C. B., Bigelow D. J., Smith R. D., Paša-Tolić L., Squier T. C., Identification of a denitrase activity against calmodulin in activated macrophages using high-field liquid chromatography-FTICR mass spectrometry. Biochemistry 2007 46 37 10498 10505 2-s2.0-34548681412 10.1021/bi7009713 (Pubitemid 47417245)
129. Kang M., Akbarali H. I., Denitration of L-type calcium channel. FEBS Letters 2008 582 20 3033 3036 2-s2.0-49649129362 10.1016/j.febslet.2008.07.042
130. Godoy L. C., Muñoz-Pinedo C., Castro L., Cardaci S., Schonhoff C. M., King M., Tortora V., Marin M., Miao Q., Jiang J. F., Kapralov A., Jemmerson R., Silkstone G. G., Patel J. N., Evans J. E., Wilson M. T., Green D. R., Kagan V. E., Radi R., Mannick J. B., Disruption of the M80-Fe ligation stimulates the translocation of cytochrome c to the cytoplasm and nucleus in nonapoptotic cells. Proceedings of the National Academy of Sciences of the United States of America 2009 106 8 2653 2658 2-s2.0-62449250253 10.1073/pnas.0809279106
131. Eccleston H. B., Andringa K. K., Betancourt A. M., King A. L., Mantena S. K., Swain T. M., Tinsley H. N., Nolte R. N., Nagy T. R., Abrams G. A., Bailey S. M., Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice. Antioxidants and Redox Signaling 2011 15 2 447 459 2-s2.0-79959524224 10.1089/ars.2010.3395
132. Annie-Jeyachristy S., Geetha A., Surendran R., Sundaram A., Lavanya K., Kumar S. J., Prakash S. A., Level of nitrated proteins in the plasma, platelets and liver of patients with liver cirrhosis. Redox Report 2009 14 6 259 266 2-s2.0-73949108162 10.1179/135100009X12525712409616
133. Spruss A., Kanuri G., Uebel K., Bischoff S. C., Bergheim I., Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxidants and Redox Signaling 2011 14 11 2121 2135 2-s2.0-79956085062 10.1089/ars.2010.3263
134. Abdelmegeed M. A., Yoo S.-H., Henderson L. E., Gonzalez F. J., Woodcroft K. J., Song B.-J., PPAR α expression protects male mice from high fat-induced nonalcoholic fatty liver. Journal of Nutrition 2011 141 4 603 610 2-s2.0-79955504163 10.3945/jn.110.135210
135. Wagnerberger S., Spruss A., Kanuri G., Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. The British Journal of Nutrition 2012 107 12 1727 1738 10.1017/S0007114511004983
136. Locatelli I., Sutti S., Vacchiano M., Bozzola C., Albano E., NF-kappaB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses. Clinical Science 2013 124 4 279 287 10.1042/CS20120289
137. Banerjee A., Abdelmegeed M. A., Jang S., Song B. J., Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators. PLoS ONE 2013 8 10 e76850
138. Begriche K., Igoudjil A., Pessayre D., Fromenty B., Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006 6 1 1 28 2-s2.0-32844458032 10.1016/j.mito.2005.10.004 (Pubitemid 43250588)
139. Yoo S. H., Park O., Henderson L. E., Abdelmegeed M. A., Moon K.-H., Song B.-J., Lack of PPAR α exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/ nitrosative stress. Toxicology Letters 2011 202 1 23 29 2-s2.0-79952036436 10.1016/j.toxlet.2011.01.013
140. Moon K.-H., Hood B. L., Mukhopadhyay P., Rajesh M., Abdelmegeed M. A., Kwon Y.-I., Conrads T. P., Veenstra T. D., Song B.-J., Pacher P., Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008 135 4 1344 1357 2-s2.0-53249125859 10.1053/j.gastro.2008.06.048
141. Hinson J. A., Pike S. L., Pumford N. R., Mayeux P. R., Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chemical Research in Toxicology 1998 11 6 604 607 2-s2.0-0031802829 10.1021/tx9800349 (Pubitemid 28285584)
142. Knight T. R., Ho Y.-S., Farhood A., Jaeschke H., Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. Journal of Pharmacology and Experimental Therapeutics 2002 303 2 468 475 2-s2.0-0036828064 10.1124/jpet.102.038968 (Pubitemid 35231215)
143. Cover C., Mansouri A., Knight T. R., Bajt M. L., Lemasters J. J., Pessayre D., Jaeschke H., Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. Journal of Pharmacology and Experimental Therapeutics 2005 315 2 879 887 2-s2.0-27144508153 10.1124/jpet.105.088898 (Pubitemid 41500754)
144. Gow A. J., Duran D., Malcolm S., Ischiropoulos H., Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Letters 1996 385 1-2 63 66 2-s2.0-0030002384 10.1016/0014-5793(96)00347-X (Pubitemid 26153471)
145. Berlett B. S., Friguet B., Yim M. B., Chock P. B., Stadtman E. R., Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: relevance to signal transduction. Proceedings of the National Academy of Sciences of the United States of America 1996 93 5 1776 1780 2-s2.0-0029879335 10.1073/pnas.93.5.1776 (Pubitemid 26082958)
146. Agarwal R., MacMillan-Crow L. A., Rafferty T. M., Saba H., Roberts D. W., Fifer E. K., James L. P., Hinson J. A., Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase. Journal of Pharmacology and Experimental Therapeutics 2011 337 1 110 116 2-s2.0-79953016028 10.1124/jpet.110.176321
147. Ni H.-M., Bockus A., Boggess N., Jaeschke H., Ding W.-X., Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 2012 55 1 222 232 2-s2.0-84155194923 10.1002/hep.24690
148. Kitam V. O., Maksymchuk O. V., Chashchyn M. O., The possible mechanisms of CYP2E1 interactions with HSP90 and the influence of ethanol on them. BMC Structural Biology 2012 12, article 33
149. Dey A., Cederbaum A. I., Geldanamycin, an inhibitor of Hsp90 increases cytochrome P450 2E1 mediated toxicity in HepG2 cells through sustained activation of the p38MAPK pathway. Archives of Biochemistry and Biophysics 2007 461 2 275 286 2-s2.0-34247567909 10.1016/j.abb.2007.02.014 (Pubitemid 46677887)
150. Dey A., Cederbaum A. I., Geldanamycin, an inhibitor of Hsp90, potentiates cytochrome P4502E1-mediated toxicity in HepG2 cells. Journal of Pharmacology and Experimental Therapeutics 2006 317 3 1391 1399 2-s2.0-33646820349 10.1124/jpet.106.101808 (Pubitemid 43764146)
151. Vadseth C., Souza J. M., Thomson L., Seagraves A., Nagaswami C., Scheiner T., Torbet J., Vilaire G., Bennett J. S., Murciano J.-C., Muzykantov V., Penn M. S., Hazen S. L., Weisel J. W., Ischiropoulos H., Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. Journal of Biological Chemistry 2004 279 10 8820 8826 2-s2.0-10744226883 10.1074/jbc.M306101200 (Pubitemid 38295940)
152. Giasson B. I., Duda J. E., Murray I. V. J., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q., Lee V. M.-Y., Oxidative damage linked to neurodegeneration by selective α -synuclein nitration in synucleinopathy lesions. Science 2000 290 5493 985 989 2-s2.0-0034602442 10.1126/science.290.5493.985
153. Ahsan H., 3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Human Immunology 2013 74 10 1392 1399 10.1016/j.humimm.2013.06.009
154. Ohmori H., Kanayama N., Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmunity Reviews 2005 4 4 224 229 2-s2.0-18944404651 10.1016/j.autrev.2004.11.011 (Pubitemid 40704707)
155. Birnboim H. C., Lemay A.-M., Lam D. K. Y., Goldstein R., Webb J. R., Cutting edge: MHC class ii-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. Journal of Immunology 2003 171 2 528 532 2-s2.0-0038107581 (Pubitemid 36871356)
156. Thomson L., Christie J., Vadseth C., Lanken P. N., Fu X., Hazen S. L., Ischiropoulos H., Identification of immunoglobulins that recognize 3-nitrotyrosine in patients with acute lung injury after major trauma. The American Journal of Respiratory Cell and Molecular Biology 2007 36 2 152 157 2-s2.0-33846904516 10.1165/rcmb.2006-0288SM (Pubitemid 46233467)
157. Nagaraj S., Gupta K., Pisarev V., Kinarsky L., Sherman S., Kang L., Herber D. L., Schneck J., Gabrilovich D. I., Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nature Medicine 2007 13 7 828 835 2-s2.0-34447118098 10.1038/nm1609 (Pubitemid 47038194)
158. Hardy L. L., Wick D. A., Webb J. R., Conversion of tyrosine to the inflammation-associated analog 3°-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells. Journal of Immunology 2008 180 9 5956 5962 2-s2.0-44449157285
159. Monroe R. K., Halvorsen S. W., Environmental toxicants inhibit neuronal Jak tyrosine kinase by mitochondrial disruption. NeuroToxicology 2009 30 4 589 598 2-s2.0-67651083454 10.1016/j.neuro.2009.03.007
160. Kurdi M., Booz G. W., JAK redux: a second look at the regulation and role of JAKs in the heart. The American Journal of Physiology-Heart and Circulatory Physiology 2009 297 5 H1545 H1556 2-s2.0-70350440089 10.1152/ajpheart.00032.2009
161. Gole M. D., Souza J. M., Choi I., Hertkorn C., Malcolm S., Foust R. F. III, Finkel B., Lanken P. N., Ischiropoulos H., Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2000 278 5 L961 L967 2-s2.0-0034073045 (Pubitemid 30351051)
162. Mantena S. K., Vaughn D. P. Jr., Andringa K. K., Eccleston H. B., King A. L., Abrams G. A., Doeller J. E., Kraus D. W., Darley-Usmar V. M., Bailey S. M., High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochemical Journal 2009 417 1 183 193 2-s2.0-58249085901 10.1042/BJ20080868
163. Boveris A., Chance B., The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochemical Journal 1973 134 3 707 716 2-s2.0-0015882341
164. Fromenty B., Pessayre D., Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines. Journal of Hepatology 1997 26 supplement 2 43 53 2-s2.0-0030917702
165. Pessayre D., Mansouri A., Fromenty B., Nonalcoholic steatosis and steatohepatitis V. mitochondrial dysfunction in steatohepatitis. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2002 282 2 G193 G199 2-s2.0-0036080591 (Pubitemid 34651674)
166. Hamanaka R. B., Chandel N. S., Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends in Biochemical Sciences 2010 35 9 505 513 2-s2.0-77956186783 10.1016/j.tibs.2010. 04.002
167. Song B.-J., Moon K.-H., Upreti V. V., Eddington N. D., Lee I. J., Mechanisms of mdma (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Current Pharmaceutical Biotechnology 2010 11 5 434 443 2-s2.0-77956563187 10.2174/138920110791591436
168. Wallace K. B., Mitochondrial off targets of drug therapy. Trends in Pharmacological Sciences 2008 29 7 361 366 2-s2.0-45849132031 10.1016/j.tips.2008.04.001
169. Bailey S. M., Pietsch E. C., Cunningham C. C., Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radical Biology and Medicine 1999 27 7-8 891 900 2-s2.0-0032847556 10.1016/S0891-5849(99)00138-0 (Pubitemid 29454593)
170. Giulivi C., Characterization and function of mitochondrial nitric-oxide synthase. Free Radical Biology and Medicine 2003 34 4 397 408 2-s2.0-0037441389 10.1016/S0891-5849(02)01298-4 (Pubitemid 36140164)
171. Janssen-Heininger Y. M. W., Mossman B. T., Heintz N. H., Forman H. J., Kalyanaraman B., Finkel T., Stamler J. S., Rhee S. G., van der Vliet A., Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radical Biology and Medicine 2008 45 1 1 17 2-s2.0-45049085873 10.1016/j.freeradbiomed.2008.03.011
172. Ford E., Hughes M. N., Wardman P., Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH. Free Radical Biology and Medicine 2002 32 12 1314 1323 2-s2.0-0037096198 10.1016/S0891-5849(02)00850-X (Pubitemid 34607635)
173. Fernández-Checa J. C., Kaplowitz N., García-Ruiz C., Colell A., Mitochondrial glutathione: importance and transport. Seminars in Liver Disease 1998 18 4 389 401 2-s2.0-0032406895 (Pubitemid 29011042)
174. Davies K. J. A., Shringarpure R., Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases. Neurology 2006 66 2, supplement 1 S93 S96 2-s2.0-33644859926 (Pubitemid 43739992)
175. Pickering A. M., Davies K. J., Differential roles of proteasome and immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation of oxidized proteins. Archives of Biochemistry and Biophysics 2012 523 2 181 190 10.1016/j.abb.2012.04.018
176. Pickering A. M., Davies K. J., Degradation of damaged proteins: the main function of the 20S proteasome. Progress in Molecular Biology and Translational Science 2012 109 227 248 10.1016/B978-0-12-397863-9.00006-7
177. Caldwell S. H., de Freitas L. A. R., Park S. H., Moreno M. L. V., Redick J. A., Davis C. A., Sisson B. J., Patrie J. T., Cotrim H., Argo C. K., Al-Osaimi A., Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2009 49 6 1888 1895 2-s2.0-68949086361 10.1002/hep.22851
178. Campello S., Scorrano L., Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Reports 2010 11 9 678 684 2-s2.0-77956230098 10.1038/embor.2010.115
179. Song B.-J., Abdelmegeed M. A., Yoo S.-H., Kim B.-J., Jo S. A., Jo I., Moon K.-H., Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications. Journal of Proteomics 2011 74 12 2691 2702 2-s2.0-81055158018 10.1016/j.jprot.2011.05.013
180. Chandra D., Singh K. K., Genetic insights into OXPHOS defect and its role in cancer. Biochimica et Biophysica Acta 2011 1807 6 620 625 2-s2.0-79955604131 10.1016/j.bbabio.2010.10.023
181. Wan J., Bae M.-A., Song B.-J., Acetoaminophen-induced accumulation of 8-oxodeoxyguanosine through reduction of Ogg1 DNA repair enzyme in C6 glioma cells. Experimental and Molecular Medicine 2004 36 1 71 77 2-s2.0-1642303102 (Pubitemid 38374727)
182. Monsalve M., Borniquel S., Valle I., Lamas S., Mitochondrial dysfunction in human pathologies. Frontiers in Bioscience 2007 12 3 1131 1153 2-s2.0-34249819676 10.2741/2132 (Pubitemid 46850646)
183. Mansouri A., Fromenty B., Berson A., Robin M.-A., Grimbert S., Beaugrand M., Erlinger S., Pessayre D., Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. Journal of Hepatology 1997 27 1 96 102 2-s2.0-0030806434 10.1016/S0168-8278(97)80286-3 (Pubitemid 27357061)
184. Mansouri A., Gaou I., de Kerguenec C., Amsellem S., Haouzi D., Berson A., Moreau A., Feldmann G., Letteron P., Pessayre D., Fromenty B., An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999 117 1 181 190 2-s2.0-0032990245 10.1016/S0016-5085(99) 70566-4 (Pubitemid 29297636)
185. Ding W.-X., Li M., Yin X.-M., Selective taste of ethanol-induced autophagy for mitochondria and lipid droplets. Autophagy 2011 7 2 248 249 2-s2.0-79551554585 10.4161/auto.7.2.14347
186. Lieber C. S., Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004 34 1 9 19 2-s2.0-12844288099 10.1016/j.alcohol.2004.07.008 (Pubitemid 40163989)
187. Gao B., Bataller R., Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011 141 5 1572 1585 2-s2.0-80054872790 10.1053/j.gastro.2011.09.002
188. Lin M. T., Beal M. F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006 443 7113 787 795 2-s2.0-33750347347 10.1038/nature05292 (Pubitemid 44622683)
189. Aulak K. S., Koeck T., Crabb J. W., Stuehr D. J., Proteomic method for identification of tyrosine-nitrated proteins. Methods in Molecular Biology 2004 279 151 165 2-s2.0-4444258355
190. Macmillan-Crow L. A., Thompson J. A., Immunoprecipitation of nitrotyrosine-containing proteins. Methods in Enzymology 1999 301 135 145 2-s2.0-0031740665 10.1016/S0076-6879(99)01076-9 (Pubitemid 28489774)
191. Helman M., Givol D., Isolation of nitrotyrosine-containing peptides by using an insoluble-antibody column. Biochemical Journal 1971 125 4 971 974 2-s2.0-0015177128
192. Heijnen H. F. G., van Donselaar E., Slot J. W., Fries D. M., Blachard-Fillion B., Hodara R., Lightfoot R., Polydoro M., Spielberg D., Thomson L., Regan E. A., Crapo J., Ischiropoulos H., Subcellular localization of tyrosine-nitrated proteins is dictated by reactive oxygen species generating enzymes and by proximity to nitric oxide synthase. Free Radical Biology and Medicine 2006 40 11 1903 1913 2-s2.0-33646589634 10.1016/j.freeradbiomed.2005. 09.006 (Pubitemid 43728857)
193. Dekker F F., Abello N., Wisastra R., Bischoff R., Enrichment and detection of tyrosine-nitrated proteins. Current Protocols in Protein Science 2012 Chapter 14: Unit 14.3
194. Zhang Q., Qian W.-J., Knyushko T. V., Clauss T. R. W., Purvine S. O., Moore R. J., Sacksteder C. A., Chin M. H., Smith D. J., Camp D. G. II, Bigelow D. J., Smith R. D., A method for selective enrichment and analysis of nitrotyrosine-containing peptides in complex proteome samples. Journal of Proteome Research 2007 6 6 2257 2268 2-s2.0-34250879061 10.1021/pr0606934 (Pubitemid 46985113)
195. Tsikas D., Caidahl K., Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2005 814 1 1 9 2-s2.0-10944234930 10.1016/j.jchromb.2004.10. 003 (Pubitemid 40017929)
196. Anderon L., Candidate-based proteomics in the search for biomarkers of cardiovascular disease. Journal of Physiology 2005 563, part 1 23 60 2-s2.0-14844311934 10.1113/jphysiol.2004.080473 (Pubitemid 40340365)
197. Zhan X., Desiderio D. M., The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional western blotting, and amino acid sequence determination with mass spectrometry. Biochemical and Biophysical Research Communications 2004 325 4 1180 1186 2-s2.0-8844244036 10.1016/j.bbrc.2004.10.169 (Pubitemid 39535887)
198. Zheng L., Settle M., Brubaker G., Schmitt D., Hazen S. L., Smith J. D., Kinter M., Localization of nitration and chlorination sites on apolipoprotein A-I catalysed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. Journal of Biological Chemistry 2005 280 1 38 47 2-s2.0-12844268120 10.1074/jbc.M407019200 (Pubitemid 40164962)
199. Butt Y. K.-C., Lo S. C.-L., Detecting nitrated proteins by proteomic technologies. Methods in Enzymology 2008 440 17 31 2-s2.0-44849084866 10.1016/S0076-6879(07)00802-6
200. Tsikas D., Schmidt M., Bohmer A., Zoerner A. A., Gutzki F. M., Jordan J., UPLC-MS/MS measurement of S-nitrosoglutathione (GSNO) in human plasma solves the S-nitrosothiol concentration enigma. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2013 927 147 157 10.1016/j.jchromb.2013.01.023
201. Pho D. B., Roustan C., Tot A. N. T., Pradel L.-A., Evidence for an essential glutamyl residue in yeast hexokinase. Biochemistry 1977 16 20 4533 4537 2-s2.0-0017689952 (Pubitemid 8224988)
202. Zhan X., Desiderio D. M., Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Analytical Biochemistry 2006 354 2 279 289 2-s2.0-33745218278 10.1016/j.ab.2006.05.024
203. Song B.-J., Veech R. L., Park S. S., Gelboin H. V., Gonzalez F. J., Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. Journal of Biological Chemistry 1989 264 6 3568 3572 2-s2.0-0024521525 (Pubitemid 19063417)
204. Saito C., Lemasters J. J., Jaeschke H., C-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicology and Applied Pharmacology 2010 246 1-2 8 17 2-s2.0-77953701589 10.1016/j.taap.2010.04.015
205. Jaeschke H., Gores G. J., Cederbaum A. I., Hinson J. A., Pessayre D., Lemasters J. J., Mechanisms of hepatotoxicity. Toxicological Sciences 2002 65 2 166 176 2-s2.0-0036163759 10.1093/toxsci/65.2.166 (Pubitemid 34121108)
206. Li G., Chen J. B., Wang C., Curcumin protects against acetaminophen-induced apoptosis in hepatic injury. World Journal of Gastroenterology 2013 19 42 7440 7446 10.3748/wjg.v19.i42.7440
207. Ramachandran A., Lebofsky M., Weinman S. A., Jaeschke H., The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicology and Applied Pharmacology 2011 251 3 226 233 2-s2.0-79952007967 10.1016/j.taap.2011.01.004
208. Carvalho N. R., da Rosa E. F., da Silva M. H., New therapeutic approach: diphenyl diselenide reduces mitochondrial dysfunction in acetaminophen-induced acute liver failure. PLoS ONE 2013 8 12 e81961
209. Burke A. S., MacMillan-Crow L. A., Hinson J. A., Reactive nitrogen species in acetaminophen-induced mitochondrial damage and toxicity in mouse hepatocytes. Chemical Research in Toxicology 2010 23 7 1286 1292 2-s2.0-77955353208 10.1021/tx1001755
210. Soboll S., Regulation of energy metabolism in liver. Journal of Bioenergetics and Biomembranes 1995 27 6 571 582 2-s2.0-0029563613 10.1007/BF02111655 (Pubitemid 26001615)
211. Fromenty B., Pessayre D., Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacology and Therapeutics 1995 67 1 101 154 2-s2.0-0029127584 10.1016/0163-7258(95)00012-6
212. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews Molecular Cell Biology 2010 11 10 700 714 2-s2.0-77957105977 10.1038/nrm2970
213. Bailey S. M., Robinson G., Pinner A., Chamlee L., Ulasova E., Pompilius M., Page G. P., Chhieng D., Jhala N., Landar A., Kharbanda K. K., Ballinger S., Darley-Usmar V., S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. The American Journal of Physiology-Gastrointestinal and Liver Physiology 2006 291 5 G857 G867 2-s2.0-33751082953 10.1152/ajpgi.00044.2006 (Pubitemid 44772012)
214. Darvesh A. S., Carroll R. T., Bishayee A., Geldenhuys W. J., van der Schyf C. J., Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Review of Neurotherapeutics 2010 10 5 729 745 2-s2.0-77951867859 10.1586/ern.10.42
215. Ha H.-L., Shin H.-J., Feitelson M. A., Yu D.-Y., Oxidative stress and antioxidants in hepatic pathogenesis. World Journal of Gastroenterology 2010 16 48 6035 6043 2-s2.0-78650780107 10.3748/wjg.v16.i48.6035
216. Chung M.-Y., Park H. J., Manautou J. E., Koo S. I., Bruno R. S., Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. Journal of Nutritional Biochemistry 2012 23 4 361 367 2-s2.0-84858280868 10.1016/j.jnutbio.2011.01.001
217. Musso G., Gambino R., de Michieli F., Biroli G., Premoli A., Pagano G., Bo S., Durazzo M., Cassader M., Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin a intake. The American Journal of Clinical Nutrition 2007 86 3 661 671 2-s2.0-34548804940 (Pubitemid 47435833)
218. Horvatovich P. L., Bischoff R., Current technological challenges in biomarker discovery and validation. European Journal of Mass Spectrometry 2010 16 1 101 121 2-s2.0-77149136461 10.1255/ejms.1050